Change Trend of Effluent Eosinophil During Peritoneal Dialysis-Related Peritonitis
- Conditions
- Peritonitis
- Registration Number
- NCT04594421
- Lead Sponsor
- Peking University First Hospital
- Brief Summary
A multi-center prospective cohort study will be conducted to explore the change trend of eosinophil in peritoneal dialysis effluent during peritoneal dialysis-associated peritonitis, and to explore the relationship between eosinophil increase, peritonitis severity and antibiotic use. This study will provide evidence for routine eosinophil testing
- Detailed Description
A multi-center prospective cohort study will be conducted to explore the change trend of eosinophil in peritoneal dialysis effluent during peritoneal dialysis-associated peritonitis, and to explore the relationship between eosinophil increase, peritonitis severity and antibiotic use. In this study, 100 patients with peritoneal dialysis-associated peritonitis who meet the inclusion criteria will be selected. Demographic data, laboratory variables, peritoneal fluid cytology and bacterial culture will be collected within 24 hours of peritonitis (day 1). Peritoneal fluid cytology includes leukocyte classification and eosinophilic leukocyte count will be examined at day 3, 5, 7, 10, 14, 21, 30, 60 and 90 after peritonitis. All patients will be followed up for 90 days, and their peritonitis outcome will be recorded. The primary endpoint is the prevalence of eosinophil increase in peritoneal effluent, which is defined as \>100 eosinophils/mm\^3, or \>10% eosinophils of the total non-erythrocyte count. Secondary end points are peritonitis outcome at month 1 and 3 including transfer to hemodialysis , death.
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 100
- Diagnosed as peritoneal dialysis-related peritonitis;
- Age> 14 years
- Maintenance peritoneal dialysis due to end-stage renal failure ≥3 months
- Use of lactate glucose dialysate
- Those who cannot be followed up regularly
- Reluctant to join this researcher
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Prevalence of elevated eosinophils in peritoneal dialysis effluent Feb 18,2021 to December 31,2023 eosinophil number \>100 /mm3, or the proportion of polynuclear leukocytes \>10%.
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Renal Division and Institute of Nehprology,Peking University First Hospital
🇨🇳Beijing, Beijing, China